Leflunomide Research Overview
Lefra 20mg is a pharmaceutical-grade immunosuppressive compound containing leflunomide, manufactured by Torrent Pharmaceuticals Ltd. This established pharmaceutical agent is extensively investigated in laboratory settings for its effects on immune system modulation and inflammatory pathway research. Leflunomide functions as an immunomodulatory compound that researchers examine for its unique mechanism of action in cellular studies. The compound has been a subject of scientific investigation since its development, offering researchers at Stroid UK Shop access to pharmaceutical-grade material for in-vitro studies.
Laboratory Research Applications
Research scientists investigate leflunomide’s mechanism as a dihydroorotate dehydrogenase inhibitor, which affects pyrimidine synthesis pathways in cellular models. Laboratory studies examine its effects on T-lymphocyte proliferation, inflammatory mediator production, and immune response modulation in controlled experimental conditions. Researchers also evaluate its potential interactions with other immunosuppressive compounds and its effects on various cell line cultures. The compound’s pharmacokinetic properties are studied in research settings to understand metabolite formation and cellular uptake mechanisms. Scientists investigating immune system disorders often include leflunomide in comparative studies with compounds from our leflunomide research collection. Additionally, researchers may compare its immunomodulatory effects with selective androgen receptor modulators from our SARMs category or examine potential synergistic effects with research peptides in multi-compound investigative protocols.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Leflunomide |
| Strength | 20mg per tablet |
| Manufacturer | Torrent Pharmaceuticals Ltd |
| CAS Number | 75706-12-6 |
| Molecular Formula | C₁₂H₉F₃N₂O₂ |
| Molecular Weight | 270.21 g/mol |
| Storage Conditions | Room temperature, dry environment |
Research Compliance Statement
Lefra 20mg containing leflunomide is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical use, or therapeutic applications. This pharmaceutical-grade compound is provided to qualified research institutions and licensed laboratories for scientific investigation only. Researchers must ensure proper handling protocols, maintain appropriate storage conditions, and dispose of materials according to institutional safety guidelines. All studies should be conducted in controlled laboratory environments with proper safety equipment and trained personnel.
